U.S. Senator Chris Murphy (D-Conn.) visited NanoViricides, Inc., a Shelton-based company working to develop nanotechnology-based anti-viral medicines, on Wednesday. Murphy joined founder Dr. Anil Diwan for a tour of the facility and then hosted a town hall with the company’s thirty employees. Two years ago, NanoViricides expanded to their new Shelton lab space from a smaller West Haven facility and added twenty new employees. NanoViricides is currently working on anti-viral drugs to treat a number of diseases, including Zika, H1N1, influenza, and Ebola, as well as a skin cream for treating shingles.